Vai brings over 15 years of experience in Market Access and Commercial Strategy. Her background spans strategic leadership roles across a range of therapeutic areas, with a track record of impact across oncology, immunology, respiratory, and other specialty areas. She spent a decade at Genentech, where she led cross-functional teams driving U.S. commercial strategy, portfolio optimization, and stakeholder engagement across payers, health systems, and channel partners. Earlier in her career, Vai was at Kantar Health, where she specialized in oncology market access and reimbursement strategy.
Vai’s deep expertise and strategic leadership will be instrumental as we continue to support our clients through complex commercialization and access challenges.